The Changing Landscape in Obesity Treatment
The US Food and Drug Administration (FDA) recently released a draft of their new guidance forthe development of anti-obesity medication (AOM) for weight reduction. Feedback will beaccepted until April 8. This guidance, replacing that published in 2007, attempts to incorporateboth changes to the AOM landscape and advances in our understanding of obesity as acondition. We … The Changing Landscape in Obesity Treatment